Priority initiatives squeeze science
Article Abstract:
Many UK researchers were surprised to learn that 5% of the 1995-96 research budget will be allocated to specific applied research initiatives that the government has identified as priorities. Cuts in funding for other areas of research will be made to assure funding for the priority research.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
European Parliament axes patent policy
Article Abstract:
The European Parliament voted against proposed standards for biotechnology patents in the European Community. Genetic researchers supported the standards, but environmentalists and animal rights groups oppose patents of living inventions.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
New tumor suppressor found in pancreatic cancer
Article Abstract:
Researchers have identified a tumor suppressor gene called Deleted in Pancreatic Cancer, locus 4 (DPC4) that plays an important role in pancreatic cancer. Pancreatic tumors grow aggressively if DPC4 is lost or mutated.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Hong Kong's pre-1997 science boom. Topnotch, targeted research propels National University. Is Japan a boon or a burden to U.S. industry's leadership?
- Abstracts: Epidemiology faces its limits. NCI reverses one expert panel, sides with another
- Abstracts: New French viaduct features innovative design. New soccer stadium lights up Munich. National Center focuses on pipeline infrastructure
- Abstracts: Incentives offer hope for habitat. Bringing research and teaching back together. New rule could squelch shipments
- Abstracts: Explaining te differences in domestic and cross-boundary strategic alliances in the pharmaceutical/biotech industry